小木虫葵花宝典之外刊投稿书信大全-第贰辑
摘要: 小 木 虫 出 品小木虫葵花宝典之外刊投稿书信大全第贰辑【小木虫论坛本书编写组】shwh 整理打造小木虫出品必属精品##########NextPage########## 目 录前言………………………………………………………………………… ...
我的投稿信、回复信和发现错误后的更正信
我的投稿信、回复信和发现错误后的更正信 背景情况一：我的投稿信我的Cover letter： Dear editor, We submit the paper ‘***’ to International Journal of Pharmaceutics. This paper has not been published in part and is not being considered for publication elsewhere. All authors agree to submission. This paper designed and described novel drug delivery approaches ***. They can be prepared from ***. The outstanding characteristic of *** is that ***. They showed many advantages over traditional drug carriers like liposomes or nanoparticles. This paper is appropriated to set in the ‘Pharmaceutical Nanotechnology’ section of this journal. The corresponding author’s address is *** Sincerely, *** 31-Aug-2005 背景情况二：随文章修改稿一同寄给编辑的回复信Response letter for revision： Dear Prof. ***(主管你这篇文章的编辑), We are very grateful to the reviewer for his very useful suggestions on how to make statements well in our paper. The revised paper has been rewritten and improved according to the suggestions of the reviewer. We hope it is satisfied. The answers: Firstly, some statements pointed out by the reviewer are clarified on the basis of the suggestions. Other similar improper statements are also clarified. The statement on p19 ‘***’ is deleted due to no ensured proofs. (i) In fact, some experiments were designed by us to study *** (ii) The data under Section 3.4 are about the toxicity and activity of ***. The detailed data are also supplied in the ‘Results of Supplementary Information’. |
关闭
站长推荐
站长推荐
/5 
川公网安备 51200202000012